09:28 AM EST, 02/26/2025 (MT Newswires) -- (Corrects the revenue in the headline and third paragraph.)

United Therapeutics ( UTHR ) reported Q4 net income Wednesday of $6.19 per diluted share, up from $4.36 a year earlier.

Analysts polled by FactSet expected $6.35.

Revenue for the quarter ended Dec. 31 was $735.9 million, up from $614.7 million a year earlier.

Analysts surveyed by FactSet expected $734.7 million.

Shares of the company were nearly 4% lower in recent Wednesday premarket activity.